SCHEMBL14876513

SCHEMBL14876513

CC[N+](CC)(CC)CCNc1cccc2c1C(=O)c1c(O)ccc(O)c1C2=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NSD2 O96028 2/20 0.47
▸ FGB P02675 1/20 0.47
▸ MMP14 P50281 1/20 0.47
▸ TERT O14746 6/20 0.45
▸ EGFR P00533 4/20 0.45
▸ PIM1 P11309 2/20 0.45
▸ CYP19A1 P11511 1/20 0.45
▸ MAPK1 P28482 5/20 0.43
▸ SMN1; SMN2 Q16637 5/20 0.43
▸ MAPT P10636 5/20 0.43
▸ MEN1 O00255 4/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ LMNA P02545 4/20 0.43
▸ RECQL P46063 3/20 0.43
▸ BLM P54132 3/20 0.43
▸ HTT P42858 3/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ L3MBTL1 Q9Y468 3/20 0.43
▸ POLB P06746 2/20 0.43
▸ NPSR1 Q6W5P4 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2552095 0.91 NSD2 (0.51) NSD2FGBMMP14TERTEGFR
SCHEMBL14876259 0.89 TERT (0.50) NSD2FGBMMP14TERTEGFR
SCHEMBL14876694 0.87 TERT (0.53) NSD2FGBMMP14TERTEGFR
SCHEMBL14876751 0.87 MAPT (0.54) NSD2FGBMMP14TERTEGFR
SCHEMBL14876578 0.86 CYP19A1 (0.59) NSD2TERTEGFRPIM1CYP19A1
SCHEMBL3917115 0.81 NSD2 (0.65) NSD2FGBMMP14TERTEGFR
Dimethylamine SCHEMBL28602840 0.80 NSD2 (0.60) NSD2FGBMMP14TERTEGFR
SCHEMBL14876929 0.79 MEN1 (0.55) NSD2FGBMMP14TERTEGFR
SCHEMBL5086164 0.79 TERT (0.56) NSD2FGBMMP14TERTEGFR
SCHEMBL29852887 0.79 TERT (0.56) NSD2FGBMMP14TERTEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11255761-B2 Method of analysing a cell or other biological material containing a nucleic acid BIOSTATUS LIMITED (GB) 2022-02-22 — — US disclosed
US-20150268142-A1 METHOD OF ANALYSING A CELL OR OTHER BIOLOGICAL MATERIAL CONTAINING A NUCLEIC ACID BIOSTATUS LIMITED (GB) 2015-09-24 — — US disclosed
US-9051467-B2 Method of analysing a cell or other biological material containing a nucleic acid BIOSTATUS LIMITED (GB) 2015-06-09 — — US disclosed
US-20130101994-A1 Method of Analysing a Cell or Other Biological Material Containing a Nucleic Acid BIOSTATUS LIMITED (GB) 2013-04-25 — — US disclosed
Send feedback